Failure to Provide Ordered Neuropathic Pain Medication Due to Communication and Follow-Through Gaps
Summary
The deficiency involves the facility’s failure to ensure effective pain management for a resident with chronic pain, as required by physician orders, the care plan, and facility policy. The resident, admitted with diagnoses including epilepsy, history of traumatic brain injury, multiple muscle contractures, parkinsonism, and chronic pain, reported right shoulder/arm pain and was observed propelling himself in his wheelchair using only his feet while holding his right arm protectively against his body. His care plan identified chronic pain and a need for pain management related to impaired mobility, contractures, and muscle spasms, with goals that he would not have unrelieved pain and approaches including administering medications as ordered and referral to pain management. Review of the physician’s orders and MAR showed that the resident was prescribed Lyrica (pregabalin) 25 mg orally twice daily for neuropathic pain, with the order active from 01/10/2026 through 04/01/2026. However, from 3/26/2026 through 3/31/2026, 12 scheduled doses of Lyrica were not administered. The MAR documented these missed doses as due to “Drug/Item Unavailable,” “Drug/Item Unavailable ODS,” and comments indicating the medication was awaiting insurance approval. During this same period, progress notes contained no documentation that the medication was not administered or that any alternative scheduled pain medication was provided, despite the resident’s MDS indicating frequent pain that limited day-to-day activities and the use of high-risk medications including anticonvulsants for pain control. Interviews revealed multiple staff inactions and communication failures that contributed to the missed pain medication. The resident stated he had more pain in his right arm and had not received his routine pain medication for several days. The Unit Manager acknowledged she had not documented discussions with the pharmacy or efforts to obtain an alternative. The DON stated nurses were expected to contact the pharmacy and then the physician if there were problems obtaining medications, but the APRN and PA managing the resident’s pain reported they had not been contacted about the lack of Lyrica or the need for an alternative, and there was no prior authorization request noted. One LPN reported receiving notice from the pharmacy that the medication was not covered and that the facility would need to pay, but he did not withdraw the available e-kit dose, did not administer Lyrica, and did not seek an alternative medication. Another LPN called the pharmacy and was told there was an insurance issue but did not document the call or contact the physician herself. A third LPN, in training, followed instructions to simply request a refill in the electronic record when the medication was unavailable. Additionally, a report showed that pregabalin 25 mg was available in the automated dispensing machine, but it was not used for the resident during the period when doses were missed.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.